[Effect of the oral antidiabetic agent glibornuride on blood coagulation, blood platelets, and fibrinolysis].
D000328:Adult; D001772:Blood Cell Count; D001777:Blood Coagulation / Q000187:drug effects*; D001792:Blood Platelets / Q000187:drug effects*; D001892:Camphanes / Q000009:adverse effects / Q000494:pharmacology; D005260:Female; D005340:Fibrinogen; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000494:pharmacology*; D008297:Male; D013453:Sulfonylurea Compounds / Q000009:adverse effects / Q000494:pharmacology*; D013921:Thrombocytopenia / Q000139:chemically induced
D001892:Camphanes; D007004:Hypoglycemic Agents; D013453:Sulfonylurea Compounds; D005340:Fibrinogen
Der Einfluss des oralen Antidiabetikums Glibornurid auf Blutgerinnung, Thrombozyten und Fibrinolyse.